Corrigendum to “neonatal Uterine Bleeding: Risk Factors and Its Association with Endometriosis-Related Symptoms Later in Life” [eur. J. Obstet. Gynecol. Reprod. Biol. 293 (2024) 146–155]
Kanae Ogawa,Khaleque N. Khan,Haruo Kuroboshi,Akemi Koshiba,Go Horiguchi,Satoshi Teramukai,Akira Fujishita,Kyoko Itoh,Sun-Wei Guo,Jo Kitawaki,Taisuke Mori
DOI: https://doi.org/10.1016/j.ejogrb.2024.02.004
2024-01-01
Abstract:The authors regret “We are very sorry for the careless printing mistake in the proper alignment of case numbers in Table 2, Table 3 of the mentioned article. These case numbers [(n = 25) and (n = 782)] should be read above the line and below NUB+ cases and NUB- cases, respectively, in each of Table 2 and Table 3. We would like to apologize for any inconvenience caused.” The authors would like to apologise for any inconvenience caused:Table 2Characteristics of 807 newborn babies born with and without visible uterine bleeding during the period of 2013–2017NUB+ casesNUB- casesp value(n = 25)(n = 782)Gestational age (week) mean ± SD39.2 ± 1.337.5 ± 2.6<0.0001 median (range)40 (36–41)38 (22–41) *missing data03Body height (cm.) mean ± SD48.0 ± 3.646.8 ± 3.80.045 median (range)49 (35–52)47.5 (26–55) *missing data024Body weight (g) mean ± SD2923.0 ± 430.32694.5 ± 605.40.040 median (range)3010 (1843–3828)2768 (482–4370) *missing data03Head circumference (cm.) mean ± SD33.7 ± 1.332.9 ± 2.20.013 median (range)34 (29.7–35.0)33 (21.1–54.0) *missing data031Chest circumference (cm.) mean ± SD31.8 ± 1.630.7 ± 2.70.045 median (range)32 (28.5–34.5)31 (18.4–37.5) *missing data032Apgar score, 1 min mean ± SD8.7 ± 1.28.1 ± 2.20.167 median (range)9 (5–10)9 (0–10) *missing data07Apgar score, 5 min mean ± SD9.4 ± 1.39.0 ± 1.90.143 median (range)10 (5–10)10 (0–10) *missing data06Blood pH, umbilical cord mean ± SD7.285 ± 0.0487.297 ± 0.0750.106 median (range)7.288 (7.159–7.400)7.305 (6.872–7.529) *missing data1175**Associated Fetal disease Present, n (%)7 (28)175 (22.4)0.473 Absent, n (%)18 (72)607 (77.6)Continuous variables were compared between groups using Wilcoxon rank sum test and categorical variables were compared using Fisher’s exact test.*This informations is not included in data analysis.**Associated fetal disease includes congenital fetal diseases, fetal growth restriction. Open table in a new tab Table 3Maternal characteristics of 807 newborn babies born with and without visible uterine bleeding during the period of 2013–2017NUB+ casesNUB− casesp value(n = 25)(n = 782)Maternal age (years) mean ± SD31.2 ± 5.132.8 ± 5.60.124 median (range)31 (21–40)33 (16–47)Body height (cm.) mean ± SD158.5 ± 5.1158.4 ± 5.80.899 median (range)159 (146–168.8)158 (139–175) *missing data06Body weight (kg.) mean ± SD60.9 ± 7.362.6 ± 9.70.401 median (range)59.5 (49.8–76.6)61.2 (40–110.3) *missing data05BMI (kg/m2) mean ± SD24.2 ± 2.525.0 ± 3.50.498 median (range)24.3 (18.3–29.3)24.4 (16.0–42.4) *missing data010Blood type, n (%) A8 (32)294 (37.6)0.303 B8 (32)175 (22.4) O7 (28)240 (30.7) AB2 (8)72 (9.2) *missing data01 Rh+25 (100)777 (99.5)0.719 Rh−0 (0)4 (0.5) *missing data01Primipara, n (%)18 (72)371 (47.4)0.023Multipara, n (%)7 (28)411 (52.6)Pattern of pregnancy Singleton, n (%)24 (96)730 (93.4)0.626 Twin, n (%)1 (4)50 (6.3) Triplet, n (%)0 (0)2 (0.3)Blood loss, vaginal delivery (mL)n = 21n = 471 mean ± SD807.5 ± 528.1716.7 ± 437.60.368 median (range)652 (304–2608)597 (66–3143) *missing data01Blood loss, Caesarian delivery (mL)n = 4n = 310 mean ± SD675.4 ± 173.7982.5 ± 650.60.345 median (range)629.5 (520–924)811 (174–4550)**Coexisting diseases Present, n (%)7 (28)252 (32.2)0.828 Absent, n (%)18 (72)530 (67.8)***Complications during pregnancy Present, n (%)7 (28)374 (47.8)0.065 Absent, n (%)18 (72)408 (52.2)Infertility treatment Present, n (%)5 (20)131 (16.7)0.594 Absent, n (%)20 (80)651 (83.3)Continuous variables were compared between groups using Wilcoxon rank sum test and categorical variables were compared using Fisher’s exact test.*This information is not included in data analysis**Coexisting diseases include maternal diseases (such as gestational diabetes, fibroid, ovarian tumor, cardiovascular disease and others), infection (hepatitis B, hepatitis C, chlamydia, HTLV-1 and others)***Complications during pregnancy include preterm birth, threatened premature delivery, hypertensive disorder of pregnancy, preeclampsia, premature rupture of membranes, multiple pregnancy, placenta previa, blood type incompatible pregnancy, infection, thrombosis, placental abruption, low-lying placenta, hydramnion, oligoamnion, and other diseases. Open table in a new tab Continuous variables were compared between groups using Wilcoxon rank sum test and categorical variables were compared using Fisher’s exact test. *This informations is not included in data analysis. **Associated fetal disease includes congenital fetal diseases, fetal growth restriction. Continuous variables were compared between groups using Wilcoxon rank sum test and categorical variables were compared using Fisher’s exact test. *This information is not included in data analysis **Coexisting diseases include maternal diseases (such as gestational diabetes, fibroid, ovarian tumor, cardiovascular disease and others), infection (hepatitis B, hepatitis C, chlamydia, HTLV-1 and others) ***Complications during pregnancy include preterm birth, threatened premature delivery, hypertensive disorder of pregnancy, preeclampsia, premature rupture of membranes, multiple pregnancy, placenta previa, blood type incompatible pregnancy, infection, thrombosis, placental abruption, low-lying placenta, hydramnion, oligoamnion, and other diseases. Neonatal uterine bleeding: Risk factors and its association with endometriosis-related symptoms later in lifeEuropean Journal of Obstetrics and Gynecology and Reproductive BiologyVol. 293PreviewEndometriosis is a common gynecological multifactorial condition associated with various problems on women health such as cyclic/acyclic menstrual pain, subfertility or infertility, recurrence of the disease after treatment and malignant transformation [1]. Endometriosis affects roughly 10 % (∼190 million) of reproductive age women and girls globally ( https://www.who.int/news-room/endometriosis ). The age-standardized annual incidence for all confirmed endometriosis diagnosis was reported to be 12.5/10000 person-years among women of reproductive age. Full-Text PDF Open Access